The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
The aspirin story – from willow to wonder drug
Abstract
Summary: The story of the discovery of aspirin stretches back more than 3500 years to when bark from the willow tree was used as a pain reliever and antipyretic. It involves an Oxfordshire clergyman, scientists at a German dye manufacturer, a Nobel Prize‐winning discovery and a series of pivotal clinical trials. Aspirin is now the most commonly used drug in the world. Its role in preventing cardiovascular and cerebrovascular disease has been revolutionary and one of the biggest pharmaceutical success stories of the last century.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
BORN, G. V. R. (1962) · Nature · doi:10.1038/194927b0 · Cited by 4,294
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Hamberg, M., Svensson, J., & Samuelsson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2994 · Cited by 3,045
Sleight, R. B., Sleight, P., Parish, S., Appleby, P. N., Collins, R., & Baigent, C. (1988) · PubMed · Cited by 2,868
急性心筋梗塞の疑いのある17187症例におけるストレプトキナーゼ静脈内投与,アスピリン経口投与,上記2つの併用または無処置の無作偽試験 ISIS-2
Dienstl, F., Backer, G. D., Cairns, J., Pedersen, F., Kala, R., Boissel, J., Schroeder, R., Horgan, J., & Tognoni, G. (1988) · The Lancet · Cited by 2,754
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742c84 · Cited by 2,250
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.018 · Cited by 1,772
Rossaint, R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernández-Mondéjar, E., Filipescu, D., Hunt, B. J., Komadina, R., Nardi, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1265-x · Cited by 1,484
Lyman, G. H., Bohlke, K., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7351 · Cited by 1,371
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera
Landolfi, R., Marchioli, R., Kutti, J., Gisslinger, H., Tognoni, G., Patrono, C., & Barbui, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035572 · Cited by 1,012
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke
The Canadian Cooperative Study Group (1978) · New England Journal of Medicine · doi:10.1056/nejm197807132990201 · Cited by 957
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology
Kozek-Langenecker, S. A., Afshari, A., Albaladejo, P., Santullano, C. A. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., et al. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32835f4d5b · Cited by 909
Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
PIPER, P. J., & VANE, J. R. (1969) · Nature · doi:10.1038/223029a0 · Cited by 880
Scully, M., Hunt, B. J., Benjamin, S., Liesner, R., Rose, P., Peyvandi, F., Cheung, B., Machin, S. J., & on behalf of British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09167.x · Cited by 863
Bibbins-Domingo, K., & on behalf of the U.S. Preventive Services Task Force* (2016) · Annals of Internal Medicine · doi:10.7326/m16-0577 · Cited by 854
Algra, A. M., & Rothwell, P. M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70112-2 · Cited by 831
Baharoglu, M. I., Cordonnier, C., Salman, R. A.-S., de Gans, K., Koopman, M. M., Brand, A., Majoie, C. B., Beenen, L. F., Marquering, H. A., Vermeulen, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30392-0 · Cited by 766
(1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251801 · Cited by 759
Guidelines on the investigation and management of antiphospholipid syndrome
Keeling, D., Mackie, I., Moore, G. W., Greer, I. A., Greaves, M., & British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09037.x · Cited by 740
Self-citationHearnshaw, S. A., Logan, R. F. A., Lowe, D., Travis, S. P. L., Murphy, M. F., & Palmer, K. R. (2011) · Gut · doi:10.1136/gut.2010.228437 · Cited by 673
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B., FitzGerald, G. A., Hirsh, J., & Roth, G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.234s · Cited by 671
Aspirin for Preventing the Recurrence of Venous Thromboembolism
Becattini, C., Agnelli, G., Schenone, A., Eichinger, S., Bucherini, E., Silingardi, M., Bianchi, M., Moia, M., Ageno, W., Vandelli, M. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114238 · Cited by 620
Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
Brighton, T. A., Eikelboom, J. W., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210384 · Cited by 563
The Salt Collaborative Group (1991) · The Lancet · doi:10.1016/0140-6736(91)92233-r · Cited by 553
Elwood, P. C., Cochrane, A., Burr, M. L., Sweetnam, P. M., Williams, G., Welsby, E., Hughes, S. J., & Renton, R. (1974) · BMJ · doi:10.1136/bmj.1.5905.436 · Cited by 519
Antiphospholipid Antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke
(2004) · JAMA · doi:10.1001/jama.291.5.576 · Cited by 478 · cited 1×
“However there is evidence that people with antiphospholipid syndrome with a previous arterial event, such as a stroke, benefit equally from an anticoagulant or aspirin (Levine et al, 2004).”
BackgroundHemler, M., & Lands, W. E. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33098-3 · Cited by 437
Reilly, I., & FitzGerald, G. (1987) · Blood · doi:10.1182/blood.v69.1.180.180 · Cited by 419
IMPAIRED PLATELET/CONNECTIVE-TISSUE REACTION IN MAN AFTER ASPIRIN INGESTION
Weiss, H., & Aledort, L. (1967) · The Lancet · doi:10.1016/s0140-6736(67)91658-3 · Cited by 379
Aspirin resistance: position paper of the Working Group on Aspirin Resistance
MICHELSON, A. D., CATTANEO, M., EIKELBOOM, J. W., GURBEL, P., KOTTKE‐MARCHANT, K., KUNICKI, T. J., PULCINELLI, F. M., CERLETTI, C., & RAO, A. K. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01351.x · Cited by 325
Palumbo, A., Cavo, M., Bringhen, S., Zamagni, E., Romano, A., Patriarca, F., Rossi, D., Gentilini, F., Crippa, C., Galli, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6844 · Cited by 323
Guideline for investigation and management of adults and children presenting with a thrombocytosis
Harrison, C. N., Bareford, D., Butt, N., Campbell, P., Conneally, E., Drummond, M., Erber, W., Everington, T., Green, A. R., Hall, G. W., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08122.x · Cited by 317
Lovelock, C., Molyneux, A., & Rothwell, P. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70107-2 · Cited by 313
British Committee for Standards in Haematology
Chaffe, B., Elliott, C., Howell, C., Jones, J., Murray, S. R., Norfolk, D., Pirie, L., & Russell, J. K. (2012) · Cited by 311
ACUTE TRANSVERSE MYELITIS AS PRESENTING NEUROLOGICAL FEATURE OF LYME DISEASE
Jacques Rousseau, J., Lust, C., Zangerle, P., & Bigaignon, G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92235-x · Cited by 306
Ferraris, V. A., Saha, S. P., Oestreich, J. H., Song, H. K., Rosengart, T., Reece, T. B., Mazer, C. D., Bridges, C. R., Despotis, G. J., Jointer, K., et al. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.07.086 · Cited by 293
Some Effects of Adrenaline and Anti-Adrenaline Compounds on Platelets in vitro and in vivo
O'BRIEN, J. R. (1963) · Nature · doi:10.1038/200763a0 · Cited by 293
Larocca, A., Cavallo, F., Bringhen, S., Di Raimondo, F., Falanga, A., Evangelista, A., Cavalli, M., Stanevsky, A., Corradini, P., Pezzatti, S., et al. (2012) · Blood · doi:10.1182/blood-2011-03-344333 · Cited by 288
The discovery of aspirin: a reappraisal
Sneader, W. (2000) · BMJ · doi:10.1136/bmj.321.7276.1591 · Cited by 249
Guideline on the management of bleeding in patients on antithrombotic agents
Makris, M., Van Veen, J. J., Tait, C. R., Mumford, A. D., & Laffan, M. (2013) · British Journal of Haematology · doi:10.1111/bjh.12107 · Cited by 230
Aguilar, M. I., Hart, R., & Pearce, L. A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006186.pub2 · Cited by 208
Patrono, C., Coller, B., Dalen, J. E., Fuster, V., Gent, M., Harker, L. A., Hirsh, J., & Roth, G. (1998) · Chest · doi:10.1378/chest.114.5_supplement.470s · Cited by 190
Normalization of platelet reactivity in clopidogrel‐treated subjects
VILAHUR, G., CHOI, B. G., ZAFAR, M. U., VILES‐GONZALEZ, J. F., VORCHHEIMER, D. A., FUSTER, V., & BADIMON, J. J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02245.x · Cited by 187
Peet, T. E. (1931) · The Journal of Egyptian Archaeology · doi:10.1177/030751333101700126 · Cited by 183
Reversal of the anti‐platelet effects of aspirin and clopidogrel
Li, C., Hirsh, J., Xie, C. C., Johnston, M., & Eikelboom, J. W. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04641.x · Cited by 153
ANALGESIC ANTIPYRETIC DRUGS AS ANTAGONISTS OF BRADYKININ
COLLIER, H. O. J., & SHORLEY, P. G. (1960) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1960.tb00288.x · Cited by 136
Stone, E. (1763) · Philosophical Transactions of the Royal Society of London · doi:10.1098/rstl.1763.0033 · Cited by 135
Ll, C. (1953) · PubMed · Cited by 132
Aguilar, M. I., & Hart, R. G. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001925.pub2 · Cited by 128
Aguilar, M. I., & Hart, R. G. (2008) · Stroke · doi:10.1161/strokeaha.107.500363 · Cited by 88
Bordet, J., Négrier, C., Dargaud, Y. G., & Quellec, S. L. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-11-0870 · Cited by 88
Acetylsalicylic acid, possible preventive of coronary thrombosis.
Ll, C. (1950) · PubMed · Cited by 84
Aspirin after myocardial infarction
Glasziou, P. (1989) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1989.tb136344.x · Cited by 75
Prevention of coronary and cerebral thrombosis.
CRAVEN, L. L. (1956) · PubMed · Cited by 72
THE TREATMENT OF ACUTE RHEUMATISM BY SALICIN.
Maclagan, T. J. (1876) · The Lancet · doi:10.1016/s0140-6736(02)49509-8 · Cited by 69
Varicella with Hypoglycemia Possibly Due to Salicylates
Mortimer, E. A. (1962) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1962.02080020596008 · Cited by 54
Aspirin after Myocardial Infarction
(1980) · The Lancet · doi:10.1016/s0140-6736(80)91626-8 · Cited by 52
Untersuchungen über die wasserfreien organischen Säuren
Gerhardt, C. (1853) · Justus Liebig s Annalen der Chemie · doi:10.1002/jlac.18530870107 · Cited by 47
Aguilar, M. I., & Hart, R. G. (2005) · Stroke · doi:10.1161/01.str.0000196914.02476.2c · Cited by 39
How World War 1 changed global attitudes to war and infectious diseases
Shanks, G. D. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61786-4 · Cited by 38
Coronary thrombosis can be prevented.
CRAVEN, L. L. (2004) · PubMed · Cited by 16
Smith, T., Elwood, P. C., Keating, C., Rothwell, P. M., Detering, E., Freedman, A., Langley, R. E., Logan, R. F., Phillips, C. J., & DeCensi, A. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2014.388 · Cited by 15
Cited by
Plants as Sources of Anti-Inflammatory Agents
Nunes, C. D. R., Barreto Arantes, M., Menezes de Faria Pereira, S., Leandro da Cruz, L., de Souza Passos, M., Pereira de Moraes, L., Vieira, I. J. C., & Barros de Oliveira, D. (2020) · Molecules · doi:10.3390/molecules25163726 · Cited by 381
Advances in covalent kinase inhibitors
Abdeldayem, A., Raouf, Y. S., Constantinescu, S. N., Moriggl, R., & Gunning, P. T. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00720b · Cited by 317
The first 3500 years of aspirin history from its roots – A concise summary
Montinari, M. R., Minelli, S., & De Caterina, R. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.10.008 · Cited by 315
Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications
Akpoveso, O.-O. P., Ubah, E. E., & Obasanmi, G. (2023) · Antioxidants · doi:10.3390/antiox12010123 · Cited by 90
Metadata
- Authors
- Desborough, M. J. R., & Keeling, D. M.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2017-01-20
- Volume
- 177
- Issue
- 5
- Pages
- 674-683
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2572596693
- Cited by
- 328
- References
- 73
- FWCI
- 15.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.